Bret A Moore1, Lynette Pujol2, Scott Waltman2, David S Shearer3. 1. Warrior Resiliency Program, U.S. Army Regional Health Command, 7800 IH-10 West, Suite 300, San Antonio, TX, 78230, USA. bret.a.moore12.civ@mail.mil. 2. Warrior Resiliency Program, U.S. Army Regional Health Command, 7800 IH-10 West, Suite 300, San Antonio, TX, 78230, USA. 3. Department of Family Medicine, Madigan Army Medical Center, Joint Base Lewis-McChord, WA, USA.
Abstract
PURPOSE OF REVIEW: It is vitally important that providers treating post-traumatic stress disorder continue to stay abreast of research advances in the treatment of this disorder. This article updates the reader about advances in research in PTSD treatment in the past four years as well as the evolving recommendations of clinical practice guidelines. RECENT FINDINGS: One of the most important developments is that trauma-focused therapy (TFT) has emerged as the first-line treatment for PTSD with pharmacologic options often being noted as second-line or adjunctive. The quality and quantity of research into the treatment of PTSD continue to grow; however, the pace of research into treatment options lags behind our understanding of the development, course, and prognosis of the disorder. The development of new research-based evidence in the treatment of PTSD, both pharmacologic and psychotherapeutic, is needed and likely to necessitate frequent updates and re-evaluations of clinical practice guidelines.
PURPOSE OF REVIEW: It is vitally important that providers treating post-traumatic stress disorder continue to stay abreast of research advances in the treatment of this disorder. This article updates the reader about advances in research in PTSD treatment in the past four years as well as the evolving recommendations of clinical practice guidelines. RECENT FINDINGS: One of the most important developments is that trauma-focused therapy (TFT) has emerged as the first-line treatment for PTSD with pharmacologic options often being noted as second-line or adjunctive. The quality and quantity of research into the treatment of PTSD continue to grow; however, the pace of research into treatment options lags behind our understanding of the development, course, and prognosis of the disorder. The development of new research-based evidence in the treatment of PTSD, both pharmacologic and psychotherapeutic, is needed and likely to necessitate frequent updates and re-evaluations of clinical practice guidelines.
Entities:
Keywords:
Clinical practice guidelines; Evidence-based psychotherapy for PTSD; Pharmacotherapy for PTSD; Post-traumatic stress disorder
Authors: Bruce P Dohrenwend; J Blake Turner; Nicholas A Turse; Ben G Adams; Karestan C Koenen; Randall Marshall Journal: Science Date: 2006-08-18 Impact factor: 47.728
Authors: Jessica L Hamblen; Sonya B Norman; Jeffrey H Sonis; Andrea J Phelps; Jonathan I Bisson; Vanessa D Nunes; Odette Megnin-Viggars; David Forbes; David S Riggs; Paula P Schnurr Journal: Psychotherapy (Chic) Date: 2019-09
Authors: Edna B Foa; Carmen P McLean; Yinyin Zang; David Rosenfield; Elna Yadin; Jeffrey S Yarvis; Jim Mintz; Stacey Young-McCaughan; Elisa V Borah; Katherine A Dondanville; Brooke A Fina; Brittany N Hall-Clark; Tracey Lichner; Brett T Litz; John Roache; Edward C Wright; Alan L Peterson Journal: JAMA Date: 2018-01-23 Impact factor: 56.272
Authors: Andrea Cipriani; Taryn Williams; Adriani Nikolakopoulou; Georgia Salanti; Anna Chaimani; Jonathan Ipser; Phil J Cowen; John R Geddes; Dan J Stein Journal: Psychol Med Date: 2017-12-19 Impact factor: 7.723
Authors: Daniel J Lee; Carla W Schnitzlein; Jonathan P Wolf; Meena Vythilingam; Ann M Rasmusson; Charles W Hoge Journal: Depress Anxiety Date: 2016-04-29 Impact factor: 6.505